For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Paragon Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 14

Forward Citations = 2

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Hussam Hisham Shaheen (13 out of 14 patents)

Eric Franklin Zhu (7 out of 8 patents)

Daniel Rios (3 out of 3 patents)

4. Byron Hua Kwan (3 out of 3 patents)

5. Yuqi Liu (3 out of 3 patents)

6. Peter Evan Harwin (2 out of 2 patents)

7. Tomas Kiselak (2 out of 3 patents)

8. Tomas Kiselak (2 out of 3 patents)

9. Peter Evan Harwin (2 out of 2 patents)

10. Jacob Cole Milligan (2 out of 2 patents)

11. Michael Frank Erasmus (1 out of 9 patents)

12. Hussam Hisham Shaheen (1 out of 1 patent)

13. Gopalan Raghunathan (1 out of 1 patent)

14. Roberto Di Niro (1 out of 1 patent)

15. Luis Antonio Rodriguez-Carnero (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12760108 - INJECTABLE FORMULATIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE (2026-10-13),

2. 12715914 - IL-17 BINDING PROTEINS, COMPOSITIONS, AND METHODS OF USE THEREOF (2026-08-25),

3. 12703749 - METHOD OF TREATING INFLAMMATORY BOWEL DISEASE (2026-08-11),

4. 12673997 - PD-1 BINDING PROTEINS, VEGF AND PD-1 BISPECIFIC BINDING PROTEINS, COMPOSITIONS, AND METHODS OF USE (2026-07-07),

5. 12673988 - ALBUMIN BINDING PROTEINS AND METHODS OF USE (2026-07-07),

6. 12655208 - IL-23 BINDING PROTEIN COMPOSITIONS AND METHODS OF USE (2026-06-16),

7. 12637505 - ALBUMIN BINDING PROTEINS AND METHODS OF USE (2026-05-26),

8. 12606627 - α4β7 integrin binding proteins and methods of use (2026-04-21),

9. 12522655 - IL-23 ANTIBODY COMPOSITIONS AND METHODS OF USE (2026-01-13),

10. 12509523 - TL1A binding proteins and methods of use (2025-12-30),

11. 12466890 - TL1A binding proteins and methods of use (2025-11-11),

12. 12459994 - Albumin binding proteins and methods of use (2025-11-04),

13. 12404334 - Methods of treating gastrointestinal inflammatory disease (2025-09-02),

14. 12304956 - Dosing regimen for treating inflammatory bowel disease (2025-05-20),

Company Overview

Paragon Therapeutics, Inc. is a biotechnology company based in Waltham, MA, focused on developing innovative therapies for unmet medical needs. The organization specializes in the research and development of advanced treatments, leveraging cutting-edge technologies to address complex health challenges. With a commitment to improving patient outcomes, Paragon Therapeutics aims to transform the landscape of therapeutic options through its pioneering research initiatives and collaborative efforts in the biopharmaceutical sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

14 Patents

#102 in Waltham, MA

#1,364 in Massachusetts

#22,350 in US

#42,333 in the World

Waltham, MA, United States of America

Paragon Therapeutics, Inc.

Forward Citations = 2

21 inventors:

Hussam Hisham Shaheen (13 out of 14 patents)

Eric Franklin Zhu (7 out of 8 patents)

Daniel Rios (3 out of 3 patents)

4. Byron Hua Kwan (3 out of 3 patents)

5. Yuqi Liu (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Paragon Therapeutics, Inc.. Retrieved from https://idiyas.com/company/paragon-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…